Hutch News

‘Manufacturing scientist’ believes in the machinery that powers Fred Hutch’s cell therapies

‘Manufacturing scientist’ believes in the machinery that powers Fred Hutch’s cell therapies

Dr. Folashade Otegbeye is the recipient of the Fleischauer Family Endowed Chair in Cell and Gene Therapy Translation
Hutch NewsJuly 30, 2025
Improving T cell receptor:peptide-MHC interaction predictions

Improving T cell receptor:peptide-MHC interaction predictions

From the Bradley Lab, Public Health Sciences Division
Science SpotlightFebruary 20, 2023
The TCR Shuffle: How your genes help determine your immune response

The TCR Shuffle: How your genes help determine your immune response

From the Dr. Frederick “Erick” Matsen and Dr. Philip Bradley labs, Biostatistics and Computational Biology Program, Cancer Consortium.
Science SpotlightJune 20, 2022
T cell diversity as a measure of immune recovery following CBT

T cell diversity as a measure of immune recovery following CBT

From the Cord Blood Group and colleagues, Clinical Research Division
Science SpotlightDecember 21, 2020
Fred Hutch at ASH: Fauci fireside chat, latest on cell therapies, repairing immune function, COVID and clots — and more

Fred Hutch at ASH: Fauci fireside chat, latest on cell therapies, repairing immune function, COVID and clots — and more

The 62nd American Society of Hematology Annual Meeting and Exposition to be held virtually Dec. 5-8, 2020
News ReleasesNovember 18, 2020
Immunotherapy prevents relapse in small leukemia trial

Immunotherapy prevents relapse in small leukemia trial

Engineered T cells kept leukemia from returning in 12 high-risk patients
Hutch NewsJune 24, 2019
Our pathogenic pasts can’t hide

Our pathogenic pasts can’t hide

From the Bradley Lab, Public Health Sciences Division
Science SpotlightOctober 15, 2018
Decoding your immune system’s memories

Decoding your immune system’s memories

Hutch researchers take a step toward reading the genetic record left by a lifetime of fighting disease
Hutch NewsAugust 30, 2018
Tinkering with T cells

Tinkering with T cells

How researchers are tweaking engineered immune cells’ cancer-targeting receptors — and why it matters
Hutch NewsMay 15, 2018
An easy pairing

An easy pairing

Fred Hutch’s Harlan Robins develops a new method to match thousands of pairs of key genes needed for cancer immunotherapy
Hutch NewsAugust 19, 2015
High-throughput sequencing outpaces flow cytometry for earliest detection of cancer relapse

High-throughput sequencing outpaces flow cytometry for earliest detection of cancer relapse

Next-generation, high-speed DNA-decoding technology detects minimal residual disease in nearly double the number of leukemia patients than current gold standard method
Hutch NewsMay 21, 2012
Detecting earliest signs of cancer relapse: Study finds high-throughput sequencing outpaces flow cytometry

Detecting earliest signs of cancer relapse: Study finds high-throughput sequencing outpaces flow cytometry

Next-generation, high-speed DNA-decoding technology detects minimal residual disease in nearly double the number of leukemia patients than current gold standard method
News ReleasesMay 16, 2012
T-cell receptors reveal immune system similarities

T-cell receptors reveal immune system similarities

Finding may lead to new cancer detection, diagnostic and treatment methods
Hutch NewsSeptember 07, 2010
When it comes to the immune system, we're all more alike than previously thought, study finds

When it comes to the immune system, we're all more alike than previously thought, study finds

Finding may lead to new ways to detect, diagnose, and treat cancer and other diseases
News ReleasesSeptember 01, 2010